These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15654268)

  • 1. Endothelin receptor antagonists: clinical realities and future directions.
    Kirchengast M; Luz M
    J Cardiovasc Pharmacol; 2005 Feb; 45(2):182-91. PubMed ID: 15654268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling.
    Kirchengast M; Münter K
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):312-25. PubMed ID: 10460693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible therapeutic role of endothelin antagonists in cardiovascular disease.
    Ram CV
    Am J Ther; 2003; 10(6):396-400. PubMed ID: 14624276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonists in cardiology clinical trials.
    Neunteufl T; Berger R; Pacher R
    Expert Opin Investig Drugs; 2002 Mar; 11(3):431-43. PubMed ID: 11866670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin in cardiovascular control: the role of endothelin antagonists.
    Wenzel RR; Czyborra P; Lüscher T; Philipp T
    Curr Hypertens Rep; 1999; 1(1):79-87. PubMed ID: 10981046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelin receptor antagonists--a brief description of the new class of drugs].
    Kowalczyk A; Kołodziejczyk M; Gorąca A
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():1076-80. PubMed ID: 25228516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptor antagonists.
    Motte S; McEntee K; Naeije R
    Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor blockers in cardiovascular disease.
    Rich S; McLaughlin VV
    Circulation; 2003 Nov; 108(18):2184-90. PubMed ID: 14597580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical potential of endothelin receptor antagonists in cardiovascular medicine.
    Ferro CJ; Webb DJ
    Drugs; 1996 Jan; 51(1):12-27. PubMed ID: 8741230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.
    Krum H; Liew D
    Curr Opin Investig Drugs; 2003 Mar; 4(3):298-302. PubMed ID: 12744222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin receptor antagonists and cardiovascular diseases of aging.
    Love MP; McMurray JJ
    Drugs Aging; 2001; 18(6):425-40. PubMed ID: 11419917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor antagonists: current status and perspectives.
    Clozel M
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S65-68. PubMed ID: 10976785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders.
    Goddard J; Webb DJ
    Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
    Jacobs A; Preston IR; Gomberg-Maitland M
    Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension].
    Batyraliev TA; Makhmutkhodzhaev SA; Ekinsi E; Pataraia SA; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV
    Kardiologiia; 2007; 47(7):73-82. PubMed ID: 18260899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
    Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
    Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
    Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
    Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
    Opitz CF; Ewert R
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():1-9. PubMed ID: 16919004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.